---
title: Explicyte vs LIDE Biotech
slug_a: explicyte
slug_b: lide-biotech
site: cro
review_signal_gate: closed
canonical_path: /compare/explicyte/lide-biotech
---

# Explicyte vs LIDE Biotech

Side-by-side profile data from each company listing on this directory.

## Explicyte

- Profile: [/companies/explicyte](/companies/explicyte)

Explicyte — Oncology CRO offering FFPE target discovery, 2D/3D immuno-oncology efficacy and mechanism-of-action assays, and ISO-certified IHC/IF trial biomarker services. Serves biotech and pharma sponsors.

Services: 13. Modalities: 2. Indications: 1. Locations: 1. Certifications: 3. The strongest documented coverage currently appears in services (13).

### Services

- Discovery Research
- Target Identification & Validation
- Preclinical In Vitro Studies
- In Vitro Pharmacology
- Biomarker Assays
- Flow Cytometry Services
- Translational Research
- Immunology & Inflammation Services
- Oncology Specialty Services
- Pathology & Histology Services
- Genomics & Sequencing Services
- Proteomics Services
- Bioinformatics & Data Science

### Modalities

- Biologics (Other)
- Antibody-Drug Conjugate (ADC)

### Indications

- Oncology

### Phases

- Discovery
- Preclinical (General)
- Preclinical (IND-Enabling)

### Sourcing models

- Data not yet provided.

## LIDE Biotech

- Profile: [/companies/lide-biotech](/companies/lide-biotech)

LIDE Biotech — Oncology-focused preclinical CRO with AAALAC-accredited China-based labs offering 2300+ PDX models, MiniPDX organoid assays, and multi-omics analysis for drug discovery and development.

Services: 10. Modalities: 2. Indications: 2. Locations: 1. Certifications: 1. The strongest documented coverage currently appears in services (10).

### Services

- Preclinical In Vitro Studies
- In Vitro Pharmacology
- Preclinical In Vivo Studies
- In Vivo Efficacy Models
- Specialized & Large-Animal Models
- Biomarker Assays
- Immunology & Inflammation Services
- Oncology Specialty Services
- Genomics & Sequencing Services
- Proteomics Services

### Modalities

- Antibody-Drug Conjugate (ADC)
- Cell Therapy

### Indications

- Oncology
- Immunology

### Phases

- Discovery
- Preclinical (General)
- Preclinical (IND-Enabling)

### Sourcing models

- Full-Service Outsourcing (FSO)